Wealthspire Advisors (Maryland)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-872
Closed -$108K 2098
2019
Q1
$108K Sell
872
-46
-5% -$5.23K 0.01% 616
2018
Q4
$92K Sell
918
-16
-2% -$1.8K 0.01% 636
2018
Q3
$119K Hold
934
0.01% 617
2018
Q2
$101K Sell
934
-148
-14% -$16.1K 0.01% 704
2018
Q1
$115K Sell
1,082
-67
-6% -$7.78K 0.01% 658
2017
Q4
$135K Buy
1,149
+253
+28% +$28.6K 0.01% 608
2017
Q3
$102K Buy
896
+44
+5% +$5.08K 0.01% 700
2017
Q2
$106K Buy
852
+172
+25% +$20.4K 0.01% 679
2017
Q1
$81K Buy
680
+46
+7% +$5.21K 0.01% 665
2016
Q4
$64K Buy
634
+82
+15% +$8.79K 0.01% 712
2016
Q3
$70K Buy
552
+8
+1% +$988 0.01% 685
2016
Q2
$64K Buy
544
+88
+19% +$9.96K 0.01% 667
2016
Q1
$47K Sell
456
-25
-5% -$2.42K 0.01% 722
2015
Q4
$48K Buy
+481
New +$47.1K 0.01% 727

Other funds holding ZBH

Wealthspire Advisors (Maryland)'s ZBH Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Zimmer Biomet (ZBH) in Q2 2019, closing a stake of 872 shares — an estimated $108K sold.

Wealthspire Advisors (Maryland) first reported a position in ZBH in Q4 2015 and held it in 14 quarters. The position peaked at $135K in Q4 2017. 883 funds tracked by Wall St. Rank hold ZBH as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Zimmer Biomet position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 872 Zimmer Biomet shares in Q2 2019, an estimated $108K.
  • Wealthspire Advisors (Maryland) first reported a position in Zimmer Biomet in Q4 2015 and held it in 14 quarters.
  • Wealthspire Advisors (Maryland)'s Zimmer Biomet position peaked at $135K in Q4 2017.
  • 883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.